clinical history may provide some pointers or the therapeutic trial itself may always be instituted. However, a n objective and reliable test would be the ideal. This is why Serry's recently published preliminary findings in identifying lithium responders on the basis of a lithium excretion test is so important (Serry, 1969) . As the paper was published in this Jortrriul not long ago, it will be reviewed only briefly. In short, Serry claims that, on the basis of the results after a test dose of 1,200 mg. of lithium carbonate and estimation of the amount excreted in a fourhour specimen of urine, patients can be divided into relative retainers and relative excreters. Retainers prove to be responders and excreters to be nonresponders. This is certainly true in the case of manics. It is now established that about 75 per cent of typical manics respond very satisfactorily to lithium. It is this group that prove to be retainers, and the quarter or so who d o not respond can be shown to be excreters. It is quite impossible to differentiate the responders and the non-responders o n clinical grounds. Perhaps one o f the most important findings that Serry m:idr was the fact that such n large proportion (40 per cent in his small series) of young so-called sociopaths are in fact cyclothymes, that to a very large extent their sociopathy is merely a symptom of their cyclothymia, that they are lithium retainers, and that lithium is an essential therapeutic weapon in their total management.
BIOGENIC AMINEX AND PSYCHIATRY
In 1937, Papez proposed a "mechanism of emotion" which involved recruiting pathways through the hippocampus, fornix, mammillary bodies, bundle of Vicq d'Azyr, thalamus, cingulates and amygdalae, i.e., the rhinencephalon. This anatomical circuit has now been described in greater detail, and the theory of Papez elaborated and confirmed.
The rhinenccphalon, together with the hypothalamus and the midbrain, are the chief repositories of the biogenic amines, viz., acetyl choline, the indoleamines (chiefly serotonin) and the catecholamines (chiefly noradrenaline and doparnine) (Figure 1) .
The role of two of these, the monoamines, i.e., the indoleamines and the catecholamines, will bc eonsidered with reference to their possible function in the pathogenesis of psychiatric disorders. Serotonin is found particularly in the limbic structures, i.e., the rhinencephalon; dopamine in the extrapyramidal system; and noradrenaline in central autonomic and alerting systems. In these sites, it has been suggested that each may function as a synaptic transmitter or as a modulator of neuronal activity in functionally distinct systems of the brain.
Physiological Functions
( i ) Both catecholamines and indoleamines are important for the rcgulation of normal sleep; the alerting effect and insomnia associated with the use of M A 0 1 drugs is well known. Jouvet (1968) stressed the importance of serotonin in the control of normal sleep. Tsuchiya el ( I / . (1969) found that total sleep deprivation led to a slight increase in acetylcholine in the telencephalon, and the levels of serotonin and noradrenaline showed a transient but marked decrease. Oswald (1965) has shown that tryptophan, a precursor of serotonin, given orally before retiring will cause an abnormally early onset of paradoxical sleep. Methysergide, a serotonin blocking agent, will prevent this response. Parachlorophenylalanine, which prevents the synthesis of serotonin, is associated with sleep deprivation states in some species.
The sleep disturbances associated with many psychiatric disturbances may then be related to alterations in the brain levels of the biogenic amines, particularly of serotonin. Indeed, sleep disturbance may be one of the earliest and most dramatic symptoms of a severe depressive illness. In addition, hyperarousal states and suppression of deep sleep have also been described in the schizophrenias.
(ii) Marley el a/. (1968) suggested that serotonin might have a role in temperature regulation. Lomax er a/. (1969) argued that the catecholamines and acetyl choline are also important. Diurnal variation of temperature may be correlated with changes in levels of the biogenic amines, ACTH, steroid and melatonin levels, all of which show circadian rhythms. The biogenic amines may therefore also be associated with the regulation of the "biological clocks" (Quay, 1968; Dixit and Buckley, 1967) .
(iii) Smythies (1965) argued that the biogenic amines combined as co-modulators of normal movement. The maintenance of normal tone follows a balance between acetylcholine and dopamine in the striatal complex. Tremor seems to follow an imbalance between serotonin, noradrenaline and histamine.
CATECHOLAMINE INDOLEAMINE

NORADRENALINE DOPAMINE ADRENALINE
Clinical support for the normotonic action c . acetyl choline and dopamine is provided by the routine use of anticholinergic agents and. more recently, L-dopa in the treatment of Parkinson's disease and other extrapyraniidal system disorders. Brodie and Reid (1968) have postulated that the catecholamines and the indoleamines usually function as opposing systems in the brain. T h e "ergotropic" system is sensitive to noradrenaline, dopamine and other phenylethylamines, and is associated with greater arousal and sympathetic activity. The "trophotropic" system probably requires serotonin and is parasympathetic. lessening motor activity and responsiveness to external stimuli. This is a resting o r a recuperative system. It can be shown that amphetamines, ephedrine and other phenylethylamines ciltlse hyperactivity ;IS predicted by the theory. but 5-hydroxytryptophan produces parasympathetic signs only if given in small doses.
Drug Effects
The modulating system shows a distinction between the inhibition of the ergotropic systems (with decreased central sympathetic outflow) and the activation of the trophotropic system (with increased parasympathetic outflow).
The practical value of such a scheme is in evaluating the effect o f drugs, e.g., reserpine and chlorpromzizine, for both have ;I different mode of action yet act as tranquillizers. Chlorpromazine, which is said
to depress the sympathetic system. decreases the response of the reticular activating system to external stimuli, while reserpine. said to activate the parasympathetic system, stimulates the reticular activating system (Brodie and Shore. 19.57; Brodie, I'letscher and Shore. 19.55).
I t has beeen shown that serotonin is important in the sedative action of reserpine (Juorio and Vogt. 1968) . Flooding of the ventricles with serotonin produces a lethargic slate, and i t is probable that the free serotonin is associated with this state. Cilrlcson (1966) noted iit least two different pools of nionoamine in the brain, part of which is in inactive stores. Reserpine is thought not to act on the cell membrane, but o n the storage granules. ;in observation which argues against but doe\ not refute Brodie's hypothesis (Vogt, 1968) .
Another view i\ that of Dewhurst ( I96Xa; 1968b; 1970) who argues that the ;mines fall into 2 major groups, the excitant group "A". o r the depressant group "C". A small biphasic group (ciilletl "B") has properties of both "A" and "C".
C r o u p "A" compounds are water soluhle. unhydroxylated aniines with the general formula R.CHI.CH,.NH1, where R is plannr, and lipophilic. e.g., amphetamine, tryptamine, phenylethylamines, methyl-tryptamine. These compounds are associated predominantly with excitement, and it is this excitant action which is specifically antagonized by methysergide (Dewhurst, 1968a) .
Group "C" compounds arc hydroxylatcd. water soluble, and have the structural formula K'.CHOH.CHn.NH.CH:,, e.g., adrcnaline (noradrenaline and isoprenaline are similar). The compounds sedate if given intrathecally (this action is not to be confused with the systemic effects). Group "B" compounds have properties intermediate between "A" and "C", and include 5-hydroxytryptamine, 6-hydroxytryptaminc, dopa, alpha-methyl-dopa. Dewhurst's evidcnce (1968b) is based largely on observations with newborn chicks, and is still to be thoroughly ev;tlria ted.
All theories stress the interdependence o f catecholamines and indoleamines on each other. Alteration in the concentration of one seems to affect the concentration of the other. Competition exists between the precursors of the cerebral monoamines and this competition possibly involves the amines themselves, but in some instances their roles may be complementary.
All these functions of the biogenic amines seem to fit under the general heading of being "regulatory". They aid the organism in adapting to its changing environment (Page, 1968) .
Anxiety States and Other Neurotic Disorders
Gellhorn argued for the separation of fear and anxiety on neurophysiological grounds, for fear is accompanied by a decrease in blood pressure, heart rate and tone in striated muscle, and possibly fainting, i.e., vagal parasympathetic or trophotropic effects. (The psychological changes are feelings of overwhelming helplessness and even passivity.) The secretion of adrenaline increases with these changcs (the "anger in" reaction), i.e., in situations in which the individual does not know what to expect (Ganong, 1965 ).
Anger on the other hand, is said to bc associated with an increased output of noradrenaline (the "anger out" reaction), or in response to those stresses with which thc individual is familiar.
Thcsc same changes are also seen in chronic anxiety states, and according to Gellhorn, "Chronic anxiety is due to the simultaneous activation of the ergotropic and trophotropic systems at a high level of arousal, or psychologically speaking to fear and aggression" (Gellhorn, 1965) .
Anxiety, then, is a prolonged feeling of discomfort due to repeated "titivation" of the ergotropic system producing excessive discharges in the visceral and motor system. This latter system, in turn, rcaccentuates the heightened sensitivity of the ergotropic system. The end result seems to be a state independent of its precipitating causes, but selfperpetuating.
Severe Affective Disorders rests on 3 main observations: may precipitate a severe depressive illness;
The monoamine theory of depressive disorders (i) depletion of cerebral monoamines by any agent (ii) drugs which increase the level of cerebral monoamines may alleviate depression or produce euphoria; and (iii) abnormalities in the metabolism of the biogenic arnines have been reported in these illnesses.
The evidence for the theory has been reviewed elsewhere (Coppen, 1968; McLeod, 1970) . The theory states that "dcpressive illnesses occur when the level of amines is reduced on reactive sites in the brain and that antidepressant drugs will be those which increase the levels of amines at these sites" (Ashcroft et a/., 1965) . The converse might apply to manic disorders and antimanic treatments. Early observations on which this theory rests were: (i) Reserpine was introduced in 1952, for the treatment of hypertension. Doyle and Smirk (1954) noted depression in I 1 of 28 patients, and Lemieux cf al. ( 1953) noted dcprcssion in I5 per cent of their series. The depression usually remitted on stopping the drug, but some cases needed admission to hospital and E.C.T.
Later, other drugs were also noted to produce depressive disorders, e.g., guanethidine and alphamethyl-dopa (Ashcroft er al., I965 ).
Cortisone has been known to produce a wide variety of psychiatric disorders, including depression. Tetrabenazine, said to have an action similar to that of reserpine, has also produced depressive illness.
(ii) Iproniazid, first introduced in 1952, was given to patients with tuberculosis and produced marked elevation of mood. Other less toxic M A 0 1 drugs were then introduced for the treatment of depression, and in 1954 imipramine was introduced, followed a few years latcr by amitriptyline. The therapeutic efficacy of these drugs has been reviewed by Klerrnan and Cole (1965) .
Reserpine and its derivatives were found to release intracellular serotonin, noradrenaline, dopamine (and histamine), producing a depletion of the monoamines.
Iproniazid and its related compounds, as inhibitors of monoamine oxidase (an enzyme important for the metabolism of both serotonin and the catecholamines), led to an increase of serotonin, noradrenaline and dopamine and many other amines (Garattini and Valzelli, 1965) .
Both the indoleamine and catecholamine hypotheses of depression have been proposed, but the evidence for each of them is incomplete and often conflicting. Only when taken together with each other d o these theories overcome many of the objections raised.
Haskovec and Rysanek (1967) suggested that antidepressant drugs have a different mode of action, some working on the adrenergic neurones, others on serotonergic neurones. Protriptyline and desipramine were especially potent in the adrenergic neurones and imipramine, amitriptyline and nortriptyline were more active on the serotonergic (Page, 1968) . The clinical impression gained from these studies was that adrenergic neurones cause activation and serotonergic neurones cause mood elevation.
Schizophrenia
The biogenic amines are probably of importance in the pathogenesis of the acute schizophrenias, although final proof is still lacking.
In cases of amphetamine addiction, a schizophreniform disorder can occur which is easily confused with paranoid schizophrenia until the drug effect abates. The psychotomimetic effect of this group of drugs and others has led to an investigation for other possible metabolites of both indoleamines and catecholamines.
The methylation of dopaminc with methionine in patients with chronic schizophrenia produced an apparent exacerbation of schizophrenic symptoms (Pollin el d., 1961 ) .
The description of adrenochrome and adrenolutin in the urine of schizophrenia (Hoffer and Osmond, 1959) further stimulated research, and the "pink spot" of Friedhoff and van Winkle (1962) led to further excited interest. These compounds are both similar to mescaline, a known psychotomimetic agent.
Other researchers, however, have not been able to replicate the results under standardized conditions, and interest in these compounds has lessened.
Fischer found bufotenine, a known hallucinogen, in the urine of many persons with schizophrenic ilinew. Himwich ei (11. (1963; 1970) have also found bufotenine. dimethyl tryptamine and 5-methoxydimethyl-tryptamine in the plasma of patients with acute schizophrenia. (See Table I.) Both catccholaniines and indo!eamines may produce psychotomimetic metabolites, but whether this happens in vivo in some of the schizophrenic illnesses is not yet certain. Methylation of the monoamines is required to produce hallucinogens, and Mandell and Morgan have recently reported finding an enzyme able to do just this. The enzyme is said to be highest where serotonin levels are highest (Mandell and Morgan. 1970) .
Basic lndoleamine Structure
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Other Hallucinogenic Compounds which may produce Psychotomimetic States
Hallucinogens are usually indoles, but may also be catecholamine derivatives, the former being the more active. I t is possible that the latter orientate spatially to form indole-like compounds.
Lyscrgide (1.Sn-2.5) is of particulw interest to thc psychopharniacologist, for the drug has powerful anti-5-HT properties, and its use is frequently followed by severe depressive episodes. These states may follow immediately after the use of the drug, o r may occur many months later.
I.ysergide itself probably afiects both the metabolism and release of serotonin, possibly inhibiting the rote of prcduction and breakdown. In addition to the effect on serotonin, Leonard and Tonge (1969) have shown that hallucinogenic drugs produce decreased levels of brain noradrenaline, acconipanied by slightly elevated dopa levels. Another effect possibly derives from the ability of lyscrgide to alter the capacity of tissues to bind serotonin.
Vitamin Deficiency States
The first known association of indoleamincs and pcllagra was reported in 1921 by W. F. Tanner who wrote to Goldberger (reported by Mcister, 1965).
". . . the erythema has almost entirely disappeared . . . on treatment of pellagra with tryptophan". This succcss led Cioldberger to write, "the primary aetiological factor in pellagra is a specific defect in the amine acid supply". We now know that this is an over-simplificat ion. Pellagra is now thought to be the result of exposure to the sun by persons depleted of nicotinic acid and protein. Thc dietary deficiency is particularly common in maize eaters with diets low in nicotinic acid and tryptophan. An excess of leucine aggravates the absorption of tryptophan, and prob-;ibly accentuates the sequelae of the deficient diet.
Multiple vitamin deficiencies are more common than are single deficiencies, and a vitamin B, deficiency state often aggravates the above picture. A similar finding has been reported in a group of paticnts with infantile spasms (hypsarrythmia). and it has been asserted that some of these unfortunate children respond to ACTII and vitamin Be.
A functional pyridoxine deficiency is said to follow the activation of tryptophan-pyrrolase by oral contraceptives. The severe depression which may follow is said to be corrected by vitamin Ba (Winston, 1969) .
In patients with carcinoid tumours (argentaffinomas), the conversion of tryptophan to serotonin may rise from 1 per cent to 60 per cent. The subsequent decrease in the amount of tryptophan and nicotinic acid available may be associated with a pellagra-like picture.
The mnemonic, beloved of medical students, for pellagra -the "3-D's", dementia, diarrhoea and dermatitis -is misleading, for the psychiatric state is dependent on both the severity and the duration of the illness. Both acute and chronic brain syndromes may develop, in addition t o altered mood states and transient psychotic states.
Precursors of the catccho1:imines are also conipctitors for the uptake of tryptophnn by both the gut and nervous tissues. Ebadi, Russell and McCoy (1968) showed that an inverse relationship exists between the activity of pyridoxal kinase and the concentration of brain noradrenaline, dopa and serotonin, for when the biogcnic amine content of the brain is lowered, the activity of pyridoxal kinase rises (and v i w \versu).
I t is suggested that a definite relationship between vitamin B, content and niet:ibolisni of biogenic amincs exists. and in addition that the concentrxtion of brain biogenic amines might control the production o f the co-cnzyme pyridoxal phosphate. The inverse correlation between the two is probably ii feed-back niechanism, for thc regulatory enzymes are inhibited by thc terminal and not the intermediary metabolites.
It is probable that an alteration occurs in enzyme availability rather than in enzyme activity in response !o changes in amine concentration (Ebadi (21 NI.. 1968) .
Inborn Errors of Metabolism
Hartnup disease is transmitted through a single recessive autosomal gene. The symptoms include cerebellar ataxia, a pellagra-like rash, and mental deficiency. On occasion, the only manifestation of the discasc is a transient personality change or psychosis. These milder forms of the disease are not usually seen until late childhood or adolescence. The basic defect appears to be an intestinal transport defect for tryptophan (Cytryn and Louric, 1967) .
Excessive emphasis should not, howevcr, be placed on the tryptophan deficiency, for other amino acid metabolic disorders are also associated with mental deficiency, e.g., maple syrup disease. a disease in which there is failure to decarboxylate leucine, isoleucine and valine. A tryptophan abnormality is present in this disease, but settles when dietary restriction of the three amino acids is followed.
In phenylketonuria ( P K U ) , plasma levels of tryptophan are reduced and it is possible that the high plasma levels of phenylalanine in the disease reduces the rate of tryptophan transport by the jejunal mucosa. The behavioural abnormalities seen in PKU have been thought to relate to the consequent defect in tryptophan metabolism, particularly in the serotonin deficiency said to be present. The demonstration of this hypothesis has yet to be made, and the elaboration of the role of serotonin in this disorder is as yet unknown.
Minimal Brain Dysfunction Minimal brain dysfunction in children is now being diagnosed more frequently. The syndrome is characterized by hyperkinetic motor behaviour, distractibility and inattentiveness, low frustration tolerance and explosive behaviour. The use of amphetamines for the management of these children, with or without a tricyclic antidepressant for associated enuresis, etc., is now well established. Animal experimentation suggests that the rnodus operundi of these agents is through greater monoanline accunittlation in the brain ( W e n d e r ('I ol., 1970).
Conclusion
The importance of the biogenic nniines iis mcdiators of both normal nnd abnormal bchaviour;il states can no longer be disputed. Repeated emphasis has been placed on the intcrdcpcndcnce of the nionoamines, but it should be remembered that these observations arc of partial explanatory value only as at a biochemical and physiological level the influence of other compounds, c.g. the glucocorticoids and ACTH, through the hypothalamic-pituitary-adrenocortical pathways, mu,t also be taken into ;iccount.
While changes do occur in the conditions noted above, it cannot be assumed that the relationship is always, if ever, ;I causal one. If, however, through a n understanding of biochemical changes psychiatric illness can be stopped, prevented or treated, then their value is obvious. PKU is ii very good example of the application of such understanding.
